3D Bioprinting is an innovative technology that combines 3D printing techniques with biological materials to create complex living structures. It involves the layer-by-layer deposition of living cells, biomaterials, and support structures to construct functional tissues and organs. This revolutionary approach holds immense potential for applications in regenerative medicine, tissue engineering, and drug discovery. The process of 3D bioprinting begins with the creation of a digital model or blueprint of the desired tissue or organ. Bioinks, composed of living cells and supportive biomaterials, are then precisely deposited layer by layer to recreate the intricate architecture of natural tissues. Various printing technologies, including inkjet, extrusion, and laser-assisted methods, are employed to achieve accurate and reproducible results. Researchers are exploring 3D bioprinting to address the shortage of donor organs for transplantation. This technology allows for the fabrication of personalized tissues, reducing the risk of rejection and increasing the likelihood of successful transplantation. Additionally, 3D bioprinting serves as a powerful tool for studying diseases, drug testing, and creating in vitro models that closely mimic human physiology. Challenges in 3D bioprinting include optimizing printing parameters, ensuring cell viability, and replicating the complex vascularization necessary for larger tissue structures. Ongoing advancements in materials science, bioengineering, and computer-aided design contribute to the continuous evolution of 3D bioprinting, offering promising solutions for the future of healthcare.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy